PL315530A1 - Derivatives of 5-nitroimidazole in the form of microgranules - Google Patents

Derivatives of 5-nitroimidazole in the form of microgranules

Info

Publication number
PL315530A1
PL315530A1 PL95315530A PL31553095A PL315530A1 PL 315530 A1 PL315530 A1 PL 315530A1 PL 95315530 A PL95315530 A PL 95315530A PL 31553095 A PL31553095 A PL 31553095A PL 315530 A1 PL315530 A1 PL 315530A1
Authority
PL
Poland
Prior art keywords
microgranules
derivatives
medicinal
nitroimidazole
hand
Prior art date
Application number
PL95315530A
Other versions
PL178424B1 (en
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/en
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of PL315530A1 publication Critical patent/PL315530A1/en
Publication of PL178424B1 publication Critical patent/PL178424B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
PL95315530A 1994-01-14 1995-01-12 Derivatives of 5-nitroimidazole in the form of microgranules PL178424B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (en) 1994-01-14 1994-01-14 New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.
PCT/FR1995/000039 WO1995019168A1 (en) 1994-01-14 1995-01-12 Microgranules of 5-nitro imidazole derivatives

Publications (2)

Publication Number Publication Date
PL315530A1 true PL315530A1 (en) 1996-11-12
PL178424B1 PL178424B1 (en) 2000-04-28

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95315530A PL178424B1 (en) 1994-01-14 1995-01-12 Derivatives of 5-nitroimidazole in the form of microgranules

Country Status (19)

Country Link
JP (1) JPH09507499A (en)
KR (1) KR100320140B1 (en)
CN (1) CN1088357C (en)
AT (1) ATE187068T1 (en)
AU (1) AU705570B2 (en)
BR (1) BR9506507A (en)
CZ (1) CZ286080B6 (en)
DE (1) DE69513632T2 (en)
DK (1) DK0739201T3 (en)
ES (1) ES2139883T3 (en)
MA (1) MA23429A1 (en)
MX (1) MX9602772A (en)
NZ (1) NZ279238A (en)
OA (1) OA10583A (en)
PL (1) PL178424B1 (en)
PT (1) PT739201E (en)
RU (1) RU2152212C1 (en)
SK (1) SK282066B6 (en)
UA (1) UA28031C2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (en) * 2001-10-17 2009-09-16 武田薬品工業株式会社 High content granules of acid labile drugs
RU2220711C1 (en) * 2002-04-24 2004-01-10 Закрытое акционерное общество "Брынцалов-А" Antibacterial and antiprotozoan agent "trihobrol"
WO2016037131A1 (en) * 2014-09-05 2016-03-10 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
EP3721871A1 (en) 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Method for continuous production of a granulate agent
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346095A (en) * 1978-02-10 1982-08-24 Mercer James B Therapeutic treatment for viral hepatitis infection
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
DE69131574T2 (en) * 1990-05-14 2000-05-04 Gary R. Jernberg SURGICAL IMPLANT AND METHOD FOR EMBEDDING CHEMOTHERAPEUTICS
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.

Also Published As

Publication number Publication date
ATE187068T1 (en) 1999-12-15
RU2152212C1 (en) 2000-07-10
DK0739201T3 (en) 2000-05-01
NZ279238A (en) 1998-03-25
OA10583A (en) 2002-07-10
CZ286080B6 (en) 2000-01-12
AU1580395A (en) 1995-08-01
ES2139883T3 (en) 2000-02-16
SK91496A3 (en) 1996-12-04
PL178424B1 (en) 2000-04-28
JPH09507499A (en) 1997-07-29
SK282066B6 (en) 2001-10-08
CN1138826A (en) 1996-12-25
KR100320140B1 (en) 2002-07-02
AU705570B2 (en) 1999-05-27
MX9602772A (en) 1997-05-31
BR9506507A (en) 1997-09-09
UA28031C2 (en) 2000-10-16
DE69513632T2 (en) 2000-04-06
CN1088357C (en) 2002-07-31
PT739201E (en) 2000-05-31
DE69513632D1 (en) 2000-01-05
CZ205596A3 (en) 1996-10-16
MA23429A1 (en) 1995-10-01

Similar Documents

Publication Publication Date Title
USD395140S (en) Furcal lampholder support for use on track
MX9707334A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates.
AU9788098A (en) Iontophoretic agent delivery to the female reproductive tract
ZA973022B (en) New pharmaceutical composition with anaesthetic effect.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
AU8918998A (en) Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
AU763094C (en) Benzimidazoles, production thereof and use thereof as medicaments
USD404097S (en) Practice bat
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
NZ328639A (en) Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments
NZ330360A (en) 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
IL126714A (en) Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
CZ2000522A3 (en) Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof
EP1226836A4 (en) Suction connector and suction catheter using the connector
PL315530A1 (en) Derivatives of 5-nitroimidazole in the form of microgranules
WO2003045429A3 (en) Anti-t cell immunotoxin fusion protein and its therapeutic use
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
USD479129S1 (en) Connector for bottle co-pack
USD442718S1 (en) Dart lampholder
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
ZA986273B (en) Purine derivatives and the use for medicine thereof.
USD424127S (en) Animal puzzle
ZA989312B (en) Novel pharmaceutically active compounds, their preparation and use.
AU1399100A (en) Therapeutic treatment with immunogenic drugs

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20050112